STAMARIL, powder and solvent for injectable suspension in a multi-dose container, Vaccin de la fièvre jaune (vivant) 100 doses
Active ingredients: VIRUS DE LA FIÈVRE JAUNE, SOUCHE 17D-204 (VIVANT, ATTÉNUÉ)
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for injectable suspension100 dosesintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- STAMARIL, poudre et solvant pour suspension injectable en récipient multidose, Vaccin de la fièvre jaune (vivant)
- Pharmaceutical form
- poudre et solvant pour suspension injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 10 flacon(s) en verre de 10 dose(s) - 10 flacon(s) en verre de 5 mL
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 18 Jan 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68844917CIP73612212CIP133400936122123Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VIRUS DE LA FIÈVRE JAUNE, SOUCHE 17D-204 (VIVANT, ATTÉNUÉ)poudre | pas moins de 1000 UI · une dose de 0,5 mL après reconstitution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.